about
Rabies in Costa Rica: Documentation of the Surveillance Program and the Endemic Situation from 1985 to 2014Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme.Influence of porcine circovirus type 2 vaccination on the level of antimicrobial consumption on 65 Austrian pig farms.Cost analysis of bluetongue virus serotype 8 surveillance and vaccination programmes in Austria from 2005 to 2013.Comparison of immunogenicity and safety between two paediatric TBE vaccines.Antimicrobial consumption on Austrian dairy farms: an observational study of udder disease treatments based on veterinary medication records.Cost distribution of bluetongue surveillance and vaccination programmes in Austria and Switzerland (2007-2016).A survey of feline leukaemia virus antigenaemia among cats in eastern Austria: a retrospective analysis of serum samples routinely tested between 1996 and 2011.Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial.A meta-analysis of bovine viral diarrhoea virus (BVDV) prevalences in the global cattle populationRelationship between the probability of veterinary-diagnosed bovine mastitis occurring and farm management risk factors on small dairy farms in AustriaComparison of Defined Course Doses (DCDvet) for Blanket and Selective Antimicrobial Dry Cow Therapy on Conventional and Organic FarmsMapping the global prevalence of bovine viral diarrhoea virus infection and its associated mitigation programmesThe relationship between clinical signs and microbiological species, spa type, and antimicrobial resistance in bovine mastitis cases in Austria
P50
Q36827867-C11289F0-BF1D-4A3E-A2C8-B340E1617E81Q37917889-84A5AE60-7FC9-4FAE-8FC0-F8160024872BQ39914222-28420E1F-1D10-431E-8FAC-BB9D1B126586Q40538167-3035DB6E-D567-4979-9E94-DE80162E715EQ42996741-525935C3-79A4-4574-AD68-717A4730CBCCQ47096894-38C07069-5733-4414-B31A-970CE5B0BD35Q47549401-F96FA3F0-7611-47B1-B8AA-BF6090E55D5FQ50988742-49E48870-308D-4B2E-8FF8-C3528E1A7C38Q51001453-2008259B-F3F6-4787-AF04-09A187A16903Q57310393-4D0D073F-205C-4D0D-9D3C-F0DBD06CB790Q64113883-4B526908-5507-4CEA-B350-A2B956AEF394Q90228427-EA5A3037-2C82-4D67-86CE-AEB4A6DAEEDEQ91651477-2E2C0805-AEE1-4BBB-9D89-D0A6311817EAQ93351457-5368D3E2-003F-4D40-83B4-B1E5E8BEED11
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Clair Firth
@ast
Clair Firth
@en
Clair Firth
@es
Clair Firth
@nl
type
label
Clair Firth
@ast
Clair Firth
@en
Clair Firth
@es
Clair Firth
@nl
prefLabel
Clair Firth
@ast
Clair Firth
@en
Clair Firth
@es
Clair Firth
@nl
P1153
P106
P108
P1153
36463234000
56487355400
56845092600
P31
P496
0000-0002-4919-7786